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Abstract
Background: The term non-specific chest pain (NSCP) is applied to hospitalized patients in order to designate that
they neither have an acute coronary syndrome (ACS) nor display evidence of a coronary ischemia. The number of
NSCP patients is increasing and comprehensive guidelines specifying their optimal management have not yet
been introduced. The objective of this review was to explore the prevalence and prognosis of NSCP versus ACS
among patients recruited in consecutive series hospitalized for chest pain suspected to be ACS.
Methods: This is a systematic literature search where three databases were searched from 1990 to 14 November
2011. In addition, one database was searched for Epub ahead of print per 24 March 2012. Three inclusion criteria
were applied: 1. documentation of an unselected consecutive series of patients admitted for chest pain, where this
review is based upon two groups of patients defined as follows: a) ‘ACS/high-risk’ and b) NSCP; 2. at least 100
cases with NSCP; and 3. follow-up of hospital readmissions and mortality for at least six months.
Results: A total of 2,204 citations were screened after removal of duplicates. Out of 80 full text articles assessed for
eligibility 12 studies were included, comprising 24,829 patients (inter-study range 250 to 13,762), with 11,008 (44%)
categorized as NSCP and 13,821 (56%) as ‘ACS/high-risk’. The mean one-year total mortality rate among patients
with NSCP in nine studies was 3.2% (inter-study range 1.4% to 8.1%), with the highest mortality among patients
with pre-existing coronary heart disease (CHD). The mean one-year mortality rate among ‘ACS/high-risk’ patients
was 18.0% (inter-study range 14.0% to 19.9%) in four studies with available data. In six studies the mean one-year
readmission rate for patients with NSCP was 17.5% (inter-study range 2.5% to 40%).
Conclusions: Patients with NSCP represent a large, heterogeneous and important group. Due to co-existing CHD
in nearly 40% of these patients, their prognosis is not necessarily benign. Although their average one-year mortality
rate was almost six times lower than those with ‘ACS/high-risk’, the subset with concomitant CHD had a relatively
poor prognosis when compared with NSCP patients without evidence of CHD.
Keywords: Hospitalizations, non-specific chest pain, non-cardiac chest pain, atypical chest pain, chest pain not yet
diagnosed, acute coronary syndrome, prognosis, readmissions, mortality
Introduction
At present, early invasive management and optimal
medical treatment of patients with acute coronary syn-
drome (ACS) is well established. Many patients admitted
to hospital with chest pain suggestive of ACS, however,
do not fulfil criteria for such management due to
normal cardiac markers and/or no objective evidence of
ischemia. The term ‘non-specific chest pain’ (NSCP),
among many others (for example, non-cardiac chest
pain, atypical chest pain, chest pain not yet diagnosed),
has been introduced in order to describe the subset of
patients without coronary ischemic etiology of their
chest pain [1-4]. At present, there are no comprehensive
guidelines for optimal management of NSCP. A substan-
tial number of these patients may have pre-existing cor-
onary heart disease (CHD) and many tend to be
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patients account for a significant amount of hospital
resources. The European Society of Cardiology has
recently stated that a large number of patients classified
as low risk for an ACS (where patient history, physical
examination, electrocardiogram (ECG) and cardiac bio-
markers are not diagnostic) represent the most prevalent
group of patients admitted to hospital with chest pain,
and, thus, are the most challenging of chest pain
patients [6].
The objective of this review is to obtain information
regarding the prevalence and prognosis of NSCP in
comparison with patients with ACS. Such information
might be of importance in the optimal management of
patients with NSCP since there are no guidelines for
this important and large group. In order to minimize
selection bias, we searched only for studies of consecu-
tive, unselected patients admitted to hospital with chest
pain suspected to be ACS.
Methods
The review protocol is presented in Appendix A [see
Additional file 1]. We searched the following three elec-
tronic databases: EMBASE, MEDLINE and PsycINFO
from the year 1990 onward to 14 November 2011. In
addition we included a PubMed search for Epub articles
ahead of print as per 24 March 2012. The search strate-
gies combined text words and subject headings identify-
ing reports relating to ACS, non-specific chest pain
(NSCP, that is, chest pain not associated with current
criteria for ACS or obvious non-coronary reasons). All
citations were checked for duplications both electroni-
cally (Reference Manager) and manually. We also per-
formed highly specific searches for the incidence rate
and prognosis of NSCP, and to this end we continuously
scanned reference lists of included studies for additional
citations. Citations from reference lists considered of
adequate quality were included as ‘additional citations
identified through other sources’.
Eligible studies needed to state that consecutive
patients were admitted with chest pain in order to rule
out ACS. Only English language original articles were
accepted for inclusion. Reviews, meta-analyses, popula-
tion-based studies, abstract-only, case reports and letters
to the editor were not considered eligible.
Two investigators (VR and JEO) independently
reviewed all citations in order to identify potentially
relevant articles and resolved any discrepancies by
reaching a consensus. If two or more studies presented
the same data from a single patient population then
only one was included.
Due to expected differences in the definition of ACS,
we introduced the term ‘ACS/high-risk’ for patients
assumed to have ischemic chest pain. All other patients
were defined as NSCP provided no severe non-coronary
etiology was identified such as pulmonary disorders
(pneumonia, pleuritis, embolism, and pneumothorax),
myo-pericarditis, aortic dissection and obvious, severe
gastrointestinal disorders.
Whenever feasible, an attempt was made to subdivide
the NSCP group into those with established coronary
heart disease (history of ACS, percutaneous coronary
intervention (PCI), coronary artery bypass graft (CABG)
and angina, preferably with a positive exercise test and/
or positive findings on coronary angiography) and
patients without evidence of CHD, termed CHD +/-
respectively.
The following inclusion criteria were applied:
1. Documentation of an unselected consecutive ser-
ies of patients admitted to hospital with chest pain
suspected to be ACS. This implies that studies
requiring informed consent for follow-up data were
not included.
2. An arbitrarily chosen figure of at least 100
patients with NSCP was required to avoid small stu-
dies and any subsequent type 2 statistical errors.
3. Long-term follow-up on readmissions and/or
mortality had to be at least six months after the
index hospitalization in both subgroups.
4. Although desirable, studies without follow-up data
on ‘ACS/high risk’ patients could be included pro-
vided the other inclusion criteria were met.
Results
Study selection
A flow chart of the different phases in the study selec-
tion is presented in Figure 1. After adding additional
citations and eliminating duplicates, 2,204 citations were
screened and 80 full articles were selected for assess-
ment. The reasons for excluding 68 of these are also
listed in Figure 1. References are grouped according to
the reasons for exclusion given in Appendix B [see
Additional file 2]. Among the 12 accepted articles
(Table 1), three were additional citations identified
through other sources and one was found among ahead
of print citations.
The included studies were published between 1996 and
2012 and together include 24,829 patients. Information
on previous CHD among patients with NSCP is pro-
vided in six studies, long-term mortality for patients
with NSCP in ten and for patients with ‘ACS/high risk’
in four studies. Data on readmissions was available for
NCSP in six studies. Only one study reported readmis-
sion rates for ‘ACS/high risk’. These data are presented
in Table 1.
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Page 2 of 8Figure 1 Selection of studies Flow of information obtained from a systematic search of four databases (PUBMED, MEDLINE, EMBASE
and PsycINFO) with addition of citations identified through other sources, and presentation of full text articles that have been
evaluated and excluded for predefined reasons. ACS, acute coronary syndrome; NSCP, non-specific chest pain.
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In Panju et al.’s study [7] patients were admitted to the
Coronary Care Unit (CCU). Those with either acute
myocardial infarction (AMI) or unstable angina pectoris
(UAP) were categorized as ‘ACS/high-risk’,w i t ht h e
remaining patients categorized as NSCP in this review.
Due to co-morbidity and/or unwillingness only 100
NSCP patients were followed up for three years in
terms of mortality and readmission. Their one-year
mortality and readmission rates were 3% and 19%,
respectively.
Bholasingh et al. [8] included 2,271 patients from two
cohorts presenting with chest pain to the cardiac emer-
gency room in 1994 and 1996. The ‘ACS/high-risk
group’ comprised of patients admitted to the CCU, and
the rest, categorized as NSCP, were discharged after
normal CK-MB measurements. In the two cohorts com-
bined 653/1,480 NSCP patients who remained under
observation in the cardiac emergency room were fol-
lowed up in terms of cardiac mortality for two years.
The authors observed that in all 16 patients who experi-
enced a fatal cardiac event during follow-up CHD was
either documented before the index hospitalization or
was established as the index hospitalization discharge
diagnosis. Annual cardiac mortality rate was 1.25%.
Cassin et al. [9] studied patients admitted to the
Emergency Department (ED) for acute chest pain, with
patients categorized to ‘ACS/high-risk’ according to well
defined criteria for high-risk. The one-year mortality
rate among the 346 patients classified as NSCP was
1.5%.
In Edmon et al.’s [10] study of the efficacy and safety
of a chest pain pathway patients not deemed suitable for
the pathway were admitted directly to the CCU and
categorized as ‘ACS/high-risk’. The remaining patients
were designated to the pathway and represented the
NSCP group. The one-year mortality rate among these
154 patients was 3.3% and the readmission rate 22%.
In Conti et al.’s study [11] consecutive patients with
chest pain admitted to the ED were screened. Based
upon a validated chest pain score patients with inter-
mediate and high-risk were categorized as ‘ACS/high-
risk’. Among the remaining patients forming the NSCP
group, 1,755 with a chest pain score ≥4 were submitted
to a short-stay program in the CCU for further evalua-
tion. CHD was documented in 885 of these cases. The
six-month mortality among the remaining 870 patients
showing no evidence of CHD was 0%. For comparison,
the six-month mortality rates among 2,420 patients with
AMI and 3,764 with UAP were 10.6% and 1.1%,
respectively.
Menown et al. [12] studied consecutive patients with
ischemic-type chest pain admitted to hospital in order
to follow the prognostic impact of various markers
assessed in two separate blood samples. The ‘ACS/high-
risk’ group comprised of patients with elevated levels of
CK-MB or troponins. Among the remaining patients
categorized as NSCP, 81% had suspected/known CHD.
Their one-year mortality rate was 4% as opposed to 14%
in the ‘ACS/high risk’ group selected on the basis of car-
diac marker elevation. The one-year readmission rate of
NSCP patients was 18%.
Spalding et al. [13] included patients admitted either
to the CCU or medical assessment unit with chest pain
suspected to be of cardiac origin. The one-year mortality
rate among patients with NSCP (termed atypical chest
pain) was 2.7%, compared with 18.3% among ‘ACS/high
Table 1 Incidence and prognosis of nonspecific chest pain among 24,829 patients admitted to hospital to rule out
acute coronary syndrome.
NSCP Follow-up of NSCP patients
Study Year n ACS/high risk
n (%)
CHD+ CHD- Total
n (%)
n Time.
month
Mortality
n (%)
Readmissions
n (%)
Panju (7) 1996 1,235 1,077 (87) 12 146 158 (13) 100 36 3 (3) 19 (19)
Bholashing (8)
a 2001 2,271 791 (35) n.a. n.a. 1,480 (65) 653 24 16 (2.5)
b n.a.
Cassin (9) 2002 570 224 (39) n.a. n.a. 346 (61) 266 12 4 (1.5) n.a.
Edmon (10) 2002 423 269 (64) 59 95 154 (36) 152 12 5 (3.3) 33 (22)
Conti (11) 2002 13,762 9,335 (68) n.a. n.a. 4,427 (32) 870 6 0 n.a.
Menown (12) 2003 391 196 (50) 158 37 195 (50) 195 12 8 (4) 46 (18)
Spalding (13) 2003 250 142 (57) 24 84 108 (43) 103 12 3 (2.9) 14 (14)
Shaver (14) 2004 999 307 (31) n.a. n.a. 692 (61) 692 12 n.a. 277 (40)
Aune (15)
a 2006 755 366 (48) 164 225 389 (52) 389 12 22 (5.7) n.a.
Aune (16,17)
a 2010 934 363 (39) 203 368 571 (61) 571 12 18 (3.2) n.a.
Leise (18) 2010 1,973 1,608 (82) n.a. n.a. 356 (18) 320 240 90 (28) 157 (49)
Ravn-Fischer (20) 2011 1,266 234 (18) n.a. n.a. 1,032 (82) 234 12 84 (8.1) n.a.
Mortality and readmission percentages have been converted to annual rates.
aCitations were not within the systematic search;
bcardiac, not total, death rate. ACS,
acute coronary syndrome; CHD, coronary heart disease; n, number; NSCP, Non-specific chest pain
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readmission rate of patients with NSCP was 14%.
Shaver et al. [14] studied patients admitted to hospital
in order to evaluate potential ACS. The ‘ACS/high-risk’
category consisted of patients who either had a positive
test for underlying CHD, had a final diagnosis of UAP
or AMI, or who died in hospital. Long-term follow-up
data comprised a high readmission rate (40%) for the
692 patients categorized as NSCP. Mortality data is not
provided for any of the two groups of patients.
Two cohorts studied by Aune et al. comprised other-
wise unselected patients admitted to hospital for chest
pain in 2003 [15] and 2006 [16,17]. The diagnostic cri-
teria for ACS were identical for both cohorts. Patients
with overt non-coronary co-morbidities explaining
their chest pain were excluded. The percentage of
NSCP increased from 52% in 2003 to 61% in 2006
[17]. The respective percentages of pre-existing CHD
among patients with NSCP were 41% in 2003 and 35%
in 2006. In the two cohorts combined the one-year
mortality rate among the 960 patients with NSCP was
4.2%, with 8.4% in 367 patients with pre-existing CHD
versus 1.5% in 593 patients without CHD. The one-
year mortality rate in 729 patients in the ‘ACS/high
risk’ group was 19.9%.
In Leise et al.’s study [18] patients were admitted to
the ED with chest pain, of whom 95% were admitted to
hospital. Patients categorized as ‘ACS/high-risk’ were
sent home from the hospital with a diagnosis of chest
pain related to CHD or specific cardiac disease, the
remaining were categorized as having NSCP. The NSCP
20-year mortality rate was 28%, indicating an average of
1.4% fatalities per year. This mortality rate was not sig-
nificantly different from an expected survival curve cre-
ated for the Minnesota white population in the period
1950-2000. In an adjusted analysis for other covariates,
only age, Charlsons Co-morbidity Index (severity-
weighted index of co-morbid conditions) [19], previous
CABG and previous valvular disease were significant
predictors for all-cause mortality among the patients
with NSCP. The readmission rate of patients with NSCP
was 49% over 20 years, indicating, on average, 2.5% per
year.
The study of Ravn-Fiscer et al. [20] comprised all
patients hospitalized with acute chest pain in three hos-
pitals within the Sahlgrenska University of Gothenburg.
The ‘ACS/high risk’ group comprised patients with ST-
segment elevation myocardial infarction (STEMI; n =
79), and UAP/non-ST-segment myocardial infarction
(NSTEMI); n = 155). The remaining patients were cate-
gorized as NSCP (termed non-ACS group). The one-
year mortality rate in the former group was 19.7%, as
opposed to 8.1% in the latter. No information on read-
missions is provided for any subgroup.
Summary of results
In total, 11,008 (44%) patients were categorized as hav-
ing NSCP according to the criteria applied in the pre-
sent review. The prevalence of NSCP ranged between
18% and 82% in the studies selected. In six studies with
available information on whether pre-existing CHD was
present or not, 620/1,575 (39%) were CHD+ as opposed
to 955/1,575 (61%) CHD-. In six studies the mean one-
year readmission rate for patients with NSCP was 17.5%
(inter-study range 2.5% to 40%).
In the NSCP group, the mean one-year mortality rate
in nine studies was 3.2% (range 1.4 to 8.1%), excluding
the study of Conti et al. [11] which had a six month
cardiac mortality rate of 0% and the study of Bholasingh
et al. [8] in which cardiac, not total, mortality was
reported. Only one study reported the mortality rate for
NSCP patients both with and without concomitant
CHD, this being 8.4% and 1.5%, respectively [17].
For patients in the ‘ACS/high-risk’ groups the mean
one-year mortality rate was 18.0% (inter-study range
14% to 19.9%) in the four studies where this was
reported. One study reported a six month mortally rate
of 10.6% for patients with AMI and 1.1% with UAP [11].
None of the selected studies provided readmission rates
for the ‘ACS/high risk’ group.
Discussion
Summary of evidence
Patients with NSCP represent a large and heterogeneous
group of patients hospitalized for chest pain. Compared
with ‘ACS/high risk’ patients they have a good long-
term prognosis. A substantial number of these patients,
however, have previously known CHD, and according to
the findings of Aune et al [15-17] such patients have a
one-year mortality within the range of both those who
have been treated with primary PCI for STEMI and
those patients with UAP. The rates of readmissions
were high, reflecting the significant burden of health
costs represented by these patients.
The introduction of more sensitive assays for tropo-
nins combined with new sensitive markers, such as
Copeptin [21] and high sensitive Troponin T [22], will
probably convert a number of non-ACS patients into
patients with NSTEMI. Accordingly, some patients with
NSCP may have potential benefit from early invasive
management and intense medical treatment in cases
w h e r et h e r ea r ep o s i t i v em a r k e r s .O nt h eo t h e rh a n d ,
the relatively poor specificity may give rise to the over-
treatment of patients with non-thrombotic causes where
the rise of cardiac markers can be seen.
In the two cohort studies of Aune et al.,N S C P
patients without CHD admitted to the ED increased
from 30% of all patients hospitalized for chest pain in
2003 to 39% in 2006 [15-17]. With the same cut-off
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CHD remained unchanged (22% in both cohorts).
Although NSCP patients without CHD have low one-
year mortality, quality of life may be influenced by their
symptoms. There is at present no good evidence by
which to characterize and quantify those who end up as
‘frequent flyers’ (FF).
The subset of NSCP patients with co-existing CHD
may be more concerned about pain that is of non-car-
diac origin, which may not worry others without a his-
tory of CHD. Nevertheless, both groups need a careful
evaluation of other possible etiologies for their non-
ischemic chest pain. Furthermore, as Zaman et al. [23]
point out, there are differences in the way chest pain is
reported both among the sexes and different ethnic
groups. Atypical chest pain was, according to their
material, reported by more women than men and by
more South Asian people than white people. They
found that typical symptoms of stable angina were asso-
ciated with coronary outcomes in all patients and that
prognostically important angina did not present atypi-
cally in women and South Asians. This implies that
white men, but indeed all patient categories, presenting
with chest pain in general should be considered both for
careful cardiac and non-cardiac assessments. Based
upon the academic literature, many patients with NSCP
may potentially profit from management of psychiatric,
gastrointestinal or musculoskeletal disorders
[7,11,13,18,24-27]. Although not apparent from studies
exploring the etiology of NSCP, it seems reasonable that
several patients may represent combinations of these
disorders, with need for various interventions. As
recently reported by White et al. [27], psychiatric etiolo-
gies for NSCP may include both alexithymia (’no words
for feelings’) and increased anxiety sensitivity, each
requiring two quite different psychological interventions.
The importance of an association between psychiatric
disorders and NSCP has recently been verified in a
population-based cohort study form Scotland [28]. Indi-
viduals with a hospital discharge diagnosis of NSCP who
have a previous psychiatric hospitalization have a greater
risk of death, all-cause, and cardiovascular-specific, at
one year, than those without. The authors suggest that a
NSCP hospitalization is an opportunity to engage and,
where appropriate, intervene to modify cardiovascular
risk in this difficult-to-reach and high-risk patient group.
At present there is no consensus on how to manage
NSCP patients. The European Society of Cardiology
(ESC) has recently advocated the widespread use of
Chest Pain Units (CPU) to which patients are admitted
following a rapid triage in the ED [6]. The CPU enables
proper monitoring and further continuous evaluation of
chest pain patients, including repeat ECG tracings, car-
diac biomarker blood drawings and cardiac imaging.
Such patients should have their evaluation completed
within 24 hours in order that they be discharged safely
or relocated to the cardiology department for medical
therapy and/or coronary angiography. Considering a
number of the possible etiologies of NSCP, a CPU
might also include a standardized investigational pro-
gram with ‘fast tracks’ to non-cardiac assessments of
unexplained patient chest pain. Potential gastrointest-
inal, psychiatric and musculoskeletal disorders may be
managed and hopefully be of value to the patients’ qual-
ity of life. Such management may be of value, since
these patients with NSCP might have high morbidity
(for example, recurrent admissions) that might be
improved by focusing away from the heart and more on
other causes of their pain. If patients are simply reas-
sured and discharged with a negative troponin test, they
will, given a lack of explanation, simply come back again
t h en e x tt i m et h e ye x p e r i e n c ep a i ni no r d e rt oh a v ea
troponin done. So far, such an additional approach to
systematically evaluate possible non-cardiac causes of
chest pain not been incorporated into the ESC
statement.
Risk of bias in the review
T h ed i a g n o s t i cc r i t e r i af o rA C Sa n d‘high-risk’ patients
have an influence upon the risk level among the remain-
ing patients with NSCP. These diagnostic criteria have
been changed and refined throughout the time period
this search covers. The prevalence of established CHD
and co-morbidity in NSCP patients is important for
their prognosis in the respective studies.
The selection criteria for patients recruited from con-
secutive series of patients hospitalized for chest pain
should minimize, but not eliminate, selection bias. In
the USA the majority of patients are admitted to the ED
or CPU, whereas in Europe patients are admitted ‘to
hospital’, CCUs or ICUs. In the 12 studies listed,
patients were admitted to ‘the hospital’ in five, to ‘the
ED’ in three, to ‘the CCU in one, to the ‘CCU or medi-
cal assessment unit’ in one, to the ‘cardiac emergency
room in one and to a ‘CPU’ in one. This bias reflects in
the fact that seven studies were from Europe, three
from the USA, one from Canada and one from New
Zealand. The risk level in these studies is inevitably
associated with the hospital scenario on admission.
Patients selected for admission to a CCU will have a
higher risk than the broad spectrum of patients
admitted to an ED. Furthermore, the criteria applied for
the ‘ACS/high-risk’ group are quite heterogeneous
across studies. During the time period covered in this
r e v i e wt h ed i a g n o s t i cc r i t e r i af o rA M Ia n dA C Sh a s
changed considerably. It is probable that a significant
number of patients with a diagnosis of NSCP in the
1990s would have had an AMI diagnosis in more recent
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group can explain the wide ranges observed for the inci-
dence and prognosis of NSCP. The importance of sub-
dividing NSCP patients into CHD+ and CHD- is espe-
cially important according to the studies of Aune et al.
[15-17], which show a nearly six-fold increase of one-
year mortality in the former group.
Limitations
Apart from the obvious selection bias both within and
across studies, a systematic search is not without pro-
blems. Important studies with more extensive and uni-
form results may well have fallen outside the search
criteria. Indeed, three of the 12 studies included in this
review were not found within the systematic search
made. In order to discover the studies by Aune et al.
[15-17] the search would have to be expanded to
include more than 100,000 citations. Several excellent
studies have not been included in the review for prede-
fined reasons, the most frequent being more or less
selected study populations (Appendix B).
No attempts were made to explore studies of the
causes of NSCP or the characteristics of so-called FF
patients. Present information on the causes of NSCP
and the proper characteristics of FFs is fairly incomplete.
Future studies should, therefore, aim towards a careful
characterization of all NSCP, including a standardized
diagnostic approach. Studies with a prospective defini-
tion of an FF with follow-up of readmissions could be
helpful in identifying those prone to ending up as a FF
versus those who do not.
Conclusions
Patients with NSCP represent a large, heterogeneous
and important group. Due to co-existing CHD in nearly
40% of these patients, their prognosis is not necessarily
benign, but still far better than those with ACS. The
introduction of new markers and sensitive essays for
cardiac necrosis may reduce the problematic subset of
non-ACS patients with CHD and instead convert them
to a diagnosis of ACS with optimal management. The
remaining patients may be offered a comprehensive
non-cardiac evaluation of their symptoms in order to
explore possible causes of their pain.
This review has highlighted the general shortcoming
of NSCP studies; a considerable selection bias within
and across studies. Guidelines for the management of
patients with NSCP are necessary.
Additional material
Additional file 1: Appendix A - The search strategy. Appendix A
presents the full search strategy of the following three electronic
databases: EMBASE, MEDLINE and PsycINFO from the year 1990 onward
to 14 November 2011. In addition a PubMed search for Epub articles
ahead of print as per 24 March 2012 is presented. The search strategies
combine text words and subject headings identifying reports relating to
ACS, non-specific chest pain.
Additional file 2: Appendix B - Rejected Citations. Full citations
evaluated and rejected according to the prospectively defined inclusion
criteria. References are grouped according to the reasons for exclusion.
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